Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
CLARIFIDE® Plus Enhances Key Financial Drivers Impacting Net Farm Income
CLARIFIDE® Plus Wellness Traits Offer Insight to Profitable Dairy Wellness Outcomes
CLARIFIDE® Plus - Wellness Is A Profitable Choice For Holsteins
CLARIFIDE® Plus - Wellness Is A Profitable Choice For Jerseys
Dr. Fernando Di Croce is currently Director of Global Genetics Technical Services at Zoetis. Prior to this role he earned a Doctor in Veterinary Medicine (DVM) degree at the University of the Center of the Buenos Aires Province (UNICEN) Tandil, Argentina. He served for six years as Head of the Department of Residency and Projects at the College of Veterinary Medicine of the University of the Center of the Buenos Aires Province (UNICEN). In 2010, Dr. Di Croce completed his PhD in Reproductive Physiology at The University of Tennessee. His research focused primarily on genomic technology applied to genetic improvement with emphasis on fertility and other economically important traits.
During his tenure at Pfizer-Zoetis as Sr. Scientist/Geneticist, he served within the Veterinarian Operations Team for provision of technical support for genomic technologies through the field force and Technical Services team. Dr. Di Croce also served as Associate Director, Regional Technical Excellence, Cattle & Equine Canada/Latin America (CLAR), he served as regional leader to provide technical perspective, support and insights on key cattle products (vaccines, pharmaceuticals, diagnostics, genetics and services).
Today, Dr. Di Croce's role is focus on a) support the commercial adoption of genomic technologies by providing the information and tools necessary to understand the implementation and value of genetic testing services, b) translating genomic research and development into solutions and c) educating internal and external stakeholders on the features, benefits, and value associated with the use of genetics products and services
Dr. Di Croce and his family are living in Kalamazoo, Michigan.